ArticleCommunications medicine2026

Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation.

Hiba Daghar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.